Litcius/Paper detail

Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

Dennis M. Black, Douglas C. Bauer, Eric Vittinghoff, Li‐Yung Lui, Andreas Grauer, Fernando Marín, Sundeep Khosla, Anne de Papp, Bruce Mitlak, Jane A. Cauley, Charles E. McCulloch, Richard Eastell, Mary Bouxsein

2020The Lancet Diabetes & Endocrinology225 citationsDOI

Topics & Concepts

MedicinePlaceboBone mineralOsteoporosisInternal medicineFemoral neckDenosumabMeta-regressionRandomized controlled trialClinical trialMeta-analysisPhysical therapyAlternative medicinePathologyBone health and osteoporosis researchParathyroid Disorders and TreatmentsVitamin D Research Studies
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials | Litcius